Predicted protein targets (top 2)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | HOGA1 | Q86XE5 | 1/20 | 0.33 |
| ▸ | IGF2R | P11717 | 2/20 | 0.32 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL22750146 | 0.75 | CA2 (0.38) | IGF2R | |
| SCHEMBL20873318 | 0.73 | — | — | |
| SCHEMBL10152858 | 0.73 | HOGA1 (0.44) | HOGA1 | |
| SCHEMBL11932305 | 0.70 | HOGA1 (0.48) | HOGA1 | |
| SCHEMBL9437143 | 0.68 | CA12 (0.42) | — | |
| SCHEMBL7262297 | 0.68 | CA12 (0.42) | — | |
| SCHEMBL13121384 | 0.67 | ENO1 (0.37) | — | |
| SCHEMBL9289211 | 0.66 | HOGA1 (0.42) | HOGA1 | |
| SCHEMBL31155107 | 0.66 | IGF2R (0.52) | IGF2R | |
| SCHEMBL18784678 | 0.66 | IGF2R (0.52) | IGF2R |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-20210401947-A1 | CONJUGATES OF A PHARMACEUTICAL AGENT AND A MOIETY CAPABLE OF BINDING TO A GLUCOSE SENSING PROTEIN | SANOFI (FR) | 2021-12-30 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20210401947-A1 | CONJUGATES OF A PHARMACEUTICAL AGENT AND A MOIETY CAPABLE OF BINDING TO A GLUCOSE SENSING PROTEIN | GPR119, SLC2A8, SLC2A4 | HOGA1 2751/4885IGF2R 26/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.